1 Min Read
Dec 14 (Reuters) - The U.S. Department of Justice accused two executives of Heritage Pharmaceuticals Inc of colluding with other generic drugmakers to fix prices, the first criminal charges stemming from a sweeping two-year investigation, Bloomberg reported.
Heritage Pharmaceuticals' former chief executive, Jeffrey Glazerof, and an ex-president, Jason Malek, were charged in Philadelphia on Wednesday, Bloomberg reported, citing court filings. (bloom.bg/2hFD6PS)
Shares of generic drugmakers such as Mylan NV, Endo International Plc and Teva Pharmaceutical Industries Ltd tumbled after the report.
A representative from Heritage Pharmaceuticals, based in Eatontown, New Jersey, was not immediately available for comment. (Reporting by Ankur Banerjee in Bengaluru; Editing by Savio D'Souza)